Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. PRL Inc
WARNING LETTER
•PRL Inc•October 26, 2018

PRL Inc – FDA Warning Letter, Oct 26, 2018

Record Details

The FDA inspected PRL, Inc. in Lobelville, TN, from October 16-26, 2018, revealing serious violations of Current Good Manufacturing Practice (CGMP) for dietary supplements (21 CFR Part 111), rendering products adulterated. Additionally, a review of product labels and the website www.forestcenterherbs.com identified serious violations of the Federal Food, Drug, and Cosmetic Act.

The products SpiroNIL, General Formula, Black Walnut, Alfalfa Herbal Tonic, Kidney Formula #1, Kidney Formula #2, and MicroNIL are deemed unapproved new drugs and misbranded drugs due to therapeutic claims on the website, indicating intended use for disease cure, mitigation, treatment, or prevention. These products are not generally recognized as safe and effective for such uses and lack FDA approval. General Formula, SpiroNIL, and Kidney Formula #2 are also misbranded as they are intended for conditions not amenable to self-diagnosis or treatment, making adequate directions for layperson use impossible.

Significant CGMP violations include: 1. Failure to establish finished product specifications for identity, purity, strength, composition, and contaminant limits for FlorAlive and Forest Center Herbs brand dietary supplements (21 CFR 111.70(e)). 2. Failure to establish packaging and labeling specifications for finished dietary supplements (21 CFR 111.70(g)). 3.

Company
PRL Inc
Inspection date
October 26, 2018
Product type
Food
Office
Division of Human and Animal Food Operations - East V
People
  • Steven Barber (District Director at FDA)
  • Kimberly A. Dutzek
View Company Profile

ID · 1e4efa26-f0b9-4461-b2e1-25beb9aa7012

Violation Codes10
21 CFR 11121 CFR 111.70(e)21 CFR 111.7321 CFR 111.7521 CFR 111.75(h)(1)21 CFR 111.95(b)(1)21 CFR 111.70(g)21 CFR 111.75(g)21 CFR 111.75(a)(1)(i)21 CFR 111.75(a)(2)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore PRL Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.